Evidence map›Paper›PMID 42245545›Full record

ReviewMolecular systems design & engineering2026

Microfluidic perspectives on chimeric antigen receptor T-cell migration in solid tumours: highlighting physical confinement as a key barrier.

Valeria Gonzalez Abrego, Matthew H W Chin, Marc-Olivier Coppens

Abstract readReview
In one paragraph

Review in Molecular systems design & engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Valeria Gonzalez AbregoCentre for Nature-Inspired Engineering & Department of Chemical Engineering, University College London Torrington Place London WC1E 7JE UK v.abrego@ucl.ac.uk matthew.chin.15@ucl.ac.uk m.coppens@ucl.ac.uk.ORCID https://orcid.org/0000-0002-8244-7249
Matthew H W ChinCentre for Nature-Inspired Engineering & Department of Chemical Engineering, University College London Torrington Place London WC1E 7JE UK v.abrego@ucl.ac.uk matthew.chin.15@ucl.ac.uk m.coppens@ucl.ac.uk.ORCID https://orcid.org/0000-0003-1633-7786
Marc-Olivier CoppensCentre for Nature-Inspired Engineering & Department of Chemical Engineering, University College London Torrington Place London WC1E 7JE UK v.abrego@ucl.ac.uk matthew.chin.15@ucl.ac.uk m.coppens@ucl.ac.uk.ORCID https://orcid.org/0000-0002-1810-2537

Funding

NGTC - UCLOT2CA278730 · NCI · UNIVERSITY COLLEGE LONDON · PI PULE, MARTIN · 2022 to 2024
$3.6M
NCI NIH HHS OT2 CA278730
6 · The paper itself

Abstract

Chimeric antigen receptor (CAR) T-cell migration and infiltration into solid tumours remains a central challenge for cancer immunotherapy. While factors such as chemokine gradients, extracellular matrix (ECM) stiffness, and immunosuppressive signalling have been well-documented, the physical confinement imposed by tumour architecture is increasingly recognized as a critical barrier. Tumour-associated ECM remodelling generates micro- and nano-scale geometric constraints that significantly alter how immune cells, particularly CAR T-cells, navigate the tumour microenvironment (TME). This article argues that physical confinement merits to be positioned at the centre of the migration challenge, not as an accessory to chemical or biochemical cues. Sustained from both fundamental cell migration biology and recent engineering advances, we highlight how designing microfluidic devices with defined geometric features can uniquely capture the role of confinement in immune cell behaviour and model this challenge. By enabling precise design control over pore size, channel geometry, and nature-inspired structures, these platforms will allow researchers to decouple confinement from other overlapping variables such as stiffness.

Identifiers

PMID42245545
PMCPMC13232377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.